BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• 

  Drug Development

  Biomarker Test Could Unlock Personalized Medicine in Alzheimer’s Disease

  Up to 40% of AD patients were found to have Lewy Bodies in their brain after succumbing to the disease.

  February 2, 2022

   · 

  5 min read

   · 

  Hayley Shasteen
• 

  Deals

  Brickell Looks to “STING” Autoimmune and Inflammatory Diseases with Carna Portfolio

  The portfolio of STING inhibitors is designed to treat autoimmune and inflammatory diseases.

  February 2, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  Drug Development

  LogicBio Crashes Following Clinical Hold of Pediatric Gene Therapy

  Shares of LogicBio Therapeutics have fallen more than 57% this morning after the company announced that its gene therapy for pediatric patients with methylmalonic acidemia has been placed on clinical hold by the U.S. Food and Drug Administration.

  February 2, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Global Roundup: Australia’s Beroni Group Opens First R&D Facility in China

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  February 2, 2022

   · 

  6 min read

   · 

  Alex Keown
• Genetown

  NanoMosaic Announces its Proteomics/Multi-Omics Early Access Program and its First System Sale to a Prestigious Boston Hospital

  NanoMosaic Inc. has announced that it has officially opened its “Proteomics/Multi-Omics Early Access Program,” to life science researchers and to CLIA certified labs.

  February 2, 2022

   · 

  2 min read
• Business

  Vector Laboratories Adds Katy Miles to its Board

  Vector Laboratories today announced the addition of Katy Miles to its Board of Directors, effective as of February 1, 2022.

  February 2, 2022

   · 

  3 min read
• Business

  Karyopharm to Report Fourth Quarter and Full Year 2021 Financial Results on February 8, 2022

  Karyopharm Therapeutics Inc. today announced it will report fourth quarter and full year 2021 financial results on Tuesday, February 8, 2022.

  February 2, 2022

   · 

  2 min read
• Genetown

  Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences - Feb 02, 2022

  Deciphera Pharmaceuticals, Inc. announced that Steve Hoerter, President and Chief Executive Officer, will present virtually at the following investor conferences.

  February 2, 2022

   · 

  1 min read
• Biotech Bay

  Tierra Biosciences Launches First-Ever Online Protein Ordering Platform for Synthetic Biology Protein Engineering

  Tierra Biosciences today announced the launch of the Tierra Protein Platform, an industry-first eCommerce portal that allows customers to get custom proteins synthesized, validated, and shipped to them in just a few clicks.

  February 2, 2022

   · 

  3 min read
• Business

  Bruker Announces Date and Time of Fourth Quarter 2021 Earnings Release and Webcast

  Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2021 financial results before market opening on Friday, February 11, 2022.

  February 2, 2022

   · 

  2 min read